While low levels of TSP‐2 expression are associated with poor prognosis in cervical carcinoma24 and ovarian carcinoma,25 high TSP‐2 expression predicts poor survival for patients with oral cancer26 and prostate cancer.23 This evidence concerns the gene THBS2 and prostate cancer.